insights_auto
Why is MYGN up 11.82%?
Dive Deeperchevron_right
MYGN:NASDAQ
Myriad Genetics Inc
$ 4.54
arrow_upward
+11.82%(+0.48) 1D
$ 4.52
arrow_downward
-0.34% (-0.016)bedtimeAfter hours
Closed: 10-р сарын 2, 16:00:01 (GMT-4) · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MYGN...
Open
$ 4.16
High
$ 4.58
Low
$ 4.16
Mkt. cap
434.25 сая
Avg. vol.
1.93 сая
Volume
2.28 сая
52-wk high
$ 8.59
52-wk low
$ 2.74
EPS
-$ 1.20
Beta
1.64
Shares outstanding
95.65 сая
No. of employees
3 мян
Open
$ 4.16
High
$ 4.58
Low
$ 4.16
Mkt. cap
434.25 сая
Avg. vol.
1.93 сая
Volume
2.28 сая
52-wk high
$ 8.59
52-wk low
$ 2.74
EPS
-$ 1.20
Beta
1.64
Shares outstanding
95.65 сая
No. of employees
3 мян
News stories
From web sources and news partners
Yahoo! Finance Canada
·
15 цагийн өмнө
Myriad Genetics (MYGN) Stock Sees Fair Value Lift As Analysts Weigh Split Targets
Yahoo Finance
·
1 өдрийн өмнө
Why Is Myriad Genetics (MYGN) Stock Soaring Today
GuruFocus
·
2 өдрийн өмнө
MYGN Maintained by Craig-Hallum -- Price Target Raised to $8.00
Profile
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity. Wikipedia
About Myriad Genetics Inc
CEOPaul J. Diaz | Paul J. Diaz
Employees2.7 мян
Founded1991
HeadquartersСолт Лэйк Сити, Юта, Америкийн Нэгдсэн Улс
Sector-
Websitemyriad.com